Browsing Tag
Turn Therapeutics
1 post
Turn Therapeutics expands its float with 7 million shares up for sale — should retail investors be cautious?
Turn Therapeutics (NASDAQ: TTRX) registers 7 million shares for resale by insiders post-direct listing. Learn how this impacts investors, liquidity, and stock sentiment.